December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Novel CRALBP Mutations Associated With Retinitis Punctata Albescens: Further Evidence Of Genetic Heterogeneity
Author Affiliations & Notes
  • MF Flynn
    Illinois Eye Institute Illinois College of Optometry Chicago IL
  • GA Fishman
    Department of Ophthalmology and Visual Sciences University of Illinois at Chicago Chicago IL
  • H Yamamoto
    Massachusetts Eye and Ear Infirmary Harvard Medical School Boston MA
  • JL Grimsby
    Massachusetts Eye and Ear Infirmary Harvard Medical School Boston MA
  • TP Dryja
    Massachusetts Eye and Ear Infirmary Harvard Medical School Boston MA
  • Footnotes
    Commercial Relationships   M.F. Flynn, None; G.A. Fishman, None; H. Yamamoto, None; J.L. Grimsby, None; T.P. Dryja, None. Grant Identification: Support: The Foundation Fighting Blindness
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 1196. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      MF Flynn, GA Fishman, H Yamamoto, JL Grimsby, TP Dryja; Novel CRALBP Mutations Associated With Retinitis Punctata Albescens: Further Evidence Of Genetic Heterogeneity . Invest. Ophthalmol. Vis. Sci. 2002;43(13):1196.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To determine the molecular genetic defects associated with retinitis punctata albescens (RPA) in five patients from three families with this autosomal recessive disease. Methods: We evaluated three probands and two clinically affected relatives with RPA. Clinical examinations included visual fields (VFs), electroretinograms (ERGs), and fundus photographs. DNA was analyzed for mutations in the 9 exons of the RLBP1 gene (encoding CRALBP) and 5 exons of the RDH5 gene (encoding 11-cis retinol dehydrogenase). The exons were individually amplified and screened for mutations by single strand conformation analysis (SSCP) and/or direct genomic sequencing. Results: Three patients, ages 7, 9, and 21, were from one family, while the remaining two patients, ages 7 and 49, were from separate families. All complained of impaired night vision within the first or second decade of life. Visual acuity ranged from 20/20 to 20/50. Peripheral visual fields were normal. All 5 patients had multiple porcelain white dots in the mid-peripheral retina and posterior pole. Four of the 5 had pigment mottling or clumping in the mid-peripheral retina while one (age 21) did not. One patient, age 49, also showed areas of choroidal atrophy in the mid-peripheral retina. The dark-adapted isolated rod ERG responses to a low intensity blue stimulus in two patients from different families, ages 7 and 21, were either nondetectable or mildly subnormal, respectively, even after 17 hours of overnight patching. The latter patient did show a 30% increase in the isolated rod b-wave amplitude after 17 hours of dark adaptation as compared to the amplitude after 40-minutes of dark adaptation. The dark-adapted maximal ERG b-wave amplitude after 40 minutes of dark adaptation was within 60 µV of the light-adapted high-intensity b-wave amplitude in 4 of the 5 patients, reflecting a marked impairment of rod function. The molecular genetic analysis results were negative for a RDH5 mutation in the three probands. Novel compound heterozygous mutations in the RLBP1 gene were found in one of three probands (age 7, isolated case). One mutation was a frameshift Gly31 (2-bp deletion) (GGA≷G--) change and the other a missense Arg151Trp (CGG≷TGG) change. Conclusion: The identification of novel RLBP1 gene mutations in only one of our three probands, all with an RPA phenotype, is evidence of genetic (nonallelic) heterogeneity in this disease.

Keywords: 562 retinal degenerations: hereditary • 420 genetics • 395 electroretinography: clinical 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×